Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Opus Genetics, Inc.(IRD) | 3,683,429 | 3,683,429 | 0 | $15.14M | $17.83M | 52.17% | +$2.69M |
| Actuate Therapeutics Inc | 10,049,996 | 10,049,996 | 0 | $15.38M | $7.84M | 22.94% | -$7.54M |
| Cognition Therapeutics, Inc.(CGTX) | 6,000,000 | 6,000,000 | 0 | $6.90M | $5.76M | 16.86% | -$1.14M |
| Rein Therapeutics Inc.(RNTX) | 2,982,375 | 2,982,375 | 0 | $3.10M | $2.40M | 7.02% | -$703.8K |
| Lantern Pharma Inc.(LTRN) | 249,397 | 235,895 | -13,502 | $1.04M | $238.3K | 0.70% | -$801.7K |
| In8bio Inc | 80,957 | 80,957 | 0 | $114.1K | $107.7K | 0.32% | -$6.5K |